Published in World J Surg on June 01, 2010
An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery (1988) 3.27
Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol (2007) 2.75
A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery (2004) 2.73
Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery (1987) 2.42
Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer (1983) 1.96
Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer (2006) 1.79
Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma". Am J Surg Pathol (1984) 1.57
Insular carcinoma: a distinct thyroid carcinoma with associated iodine-131 localization. J Nucl Med (1991) 1.50
Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer (2004) 1.26
Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery (2007) 1.09
Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World J Surg (2008) 1.04
Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg (2008) 1.02
Undifferentiated and poorly differentiated carcinoma. Semin Diagn Pathol (1985) 1.01
A review of thyroid cancer with intermediate differentiation. J Surg Oncol (2004) 1.00
Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid (2007) 0.97
Poorly differentiated thyroid carcinoma: diagnostic features and controversial issues. Endocr Pathol (2008) 0.91
Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns. Cancer (2007) 0.86
Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol (1999) 0.84
Management of low-risk papillary thyroid carcinoma: unique conventional policy in Japan and our efforts to improve the level of evidence. Surg Today (2010) 0.83
Insular component as a risk factor of thyroid carcinoma. Pathol Int (1996) 0.80
Poorly differentiated thyroid carcinoma--it is important. Am J Surg Pathol (2000) 0.79
Another dissertation on poorly differentiated carcinomas: is it really necessary? Adv Anat Pathol (1999) 0.78
Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol (2007) 2.75
A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery (2004) 2.73
New terminology for intrauterine endometrial samples: a group study by the Japanese Society of Clinical Cytology. Acta Cytol (2012) 1.99
Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Surgery (2010) 1.92
Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg (2010) 1.86
Treatment strategy for rectal carcinoids: a clinicopathological analysis of 229 cases at a single cancer institution. J Gastroenterol Hepatol (2012) 1.71
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol (2007) 1.66
Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction. Int J Cardiol (2006) 1.52
Prospective application of our novel prognostic index in the treatment of anaplastic thyroid carcinoma. Surgery (2011) 1.51
Indications for gastrectomy after incomplete EMR for early gastric cancer. Gastric Cancer (2005) 1.45
Thyroid gland: international case conference. Endocr Pathol (2002) 1.39
Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer. Cancer Sci (2014) 1.19
Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma. Thyroid (2010) 1.10
Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery (2007) 1.09
Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice. Diabetes (2011) 1.07
Bone anabolic effects of S-40503, a novel nonsteroidal selective androgen receptor modulator (SARM), in rat models of osteoporosis. Biol Pharm Bull (2003) 1.05
Long-lasting response to crizotinib in brain metastases due to EML4-ALK-rearranged non-small-cell lung cancer. BMJ Case Rep (2013) 1.05
Lymph node metastasis from undifferentiated-type mucosal gastric cancer satisfying the expanded criteria for endoscopic resection based on routine histological examination. Gastric Cancer (2010) 1.04
Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg (2008) 1.02
Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Gastric Cancer (2013) 0.99
OSNA-based novel molecular testing for lymph node metastases in colorectal cancer patients: results from a multicenter clinical performance study in Japan. Ann Surg Oncol (2011) 0.98
Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem (2002) 0.97
Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience. Jpn J Clin Oncol (2008) 0.97
Pulmonary tumor thrombotic microangiopathy caused by an ovarian cancer expressing tissue factor and vascular endothelial growth factor. Pathol Res Pract (2008) 0.97
Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial. J Clin Endocrinol Metab (2010) 0.95
Endocrine carcinoma of the stomach: clinicopathological analysis of 27 surgically treated cases in a single institute. Gastric Cancer (2012) 0.95
Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation. Pathol Res Pract (2008) 0.95
ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells. Oncol Rep (2010) 0.95
Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population. J Psychiatr Res (2012) 0.94
Therapeutic outcomes of endoscopic submucosal dissection of undifferentiated-type intramucosal gastric cancer without ulceration and preoperatively diagnosed as 20 millimetres or less in diameter. Dig Endosc (2010) 0.94
Malignant mucosal melanoma of the eustachian tube. Radiat Med (2008) 0.91
Clinical characterization of gastric lesions initially diagnosed as low-grade adenomas on forceps biopsy. Dig Endosc (2012) 0.91
Aortic aneurysms in systemic lupus erythematosus: a meta-analysis of 35 cases in the literature and two different pathogeneses. Cardiovasc Pathol (2010) 0.90
Predictors of the efficacy of FOLFIRI plus bevacizumab as second-line treatment in metastatic colorectal cancer patients. Surg Today (2011) 0.90
Real-time monitoring of continuous-wave terahertz radiation using a fiber-based, terahertz-comb-referenced spectrum analyzer. Opt Express (2009) 0.90
Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma. Virchows Arch (2014) 0.90
Loss of hrs in the central nervous system causes accumulation of ubiquitinated proteins and neurodegeneration. Am J Pathol (2008) 0.89
Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas. Dig Dis Sci (2003) 0.89
Adenocarcinoma of small intestinal type in retroperitoneal mature teratoma. Pathol Int (2010) 0.89
Growth factors stimulate expression of neuronal and glial miR-132. Neurosci Lett (2011) 0.88
Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study. Surgery (2011) 0.87
Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals. Sci Rep (2012) 0.87
A novel chemo-radiotherapy with low-dose daily cisplatin, 5-fluorouracil and doxorubicin for anaplastic thyroid carcinoma: a preliminary report. Jpn J Clin Oncol (2011) 0.87
Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J Surg (2014) 0.87
Properties of L-type amino acid transporter 1 in epidermal ovarian cancer. Int J Gynecol Cancer (2010) 0.86
Possible association of the semaphorin 3D gene (SEMA3D) with schizophrenia. J Psychiatr Res (2010) 0.86
Identification of single nucleotide polymorphisms regulating peripheral blood mRNA expression with genome-wide significance: an eQTL study in the Japanese population. PLoS One (2013) 0.86
Fascin expression in dendritic cells and tumor epithelium in thymoma and thymic carcinoma. Oncol Lett (2011) 0.86
Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation. Am J Cardiol (2011) 0.85
Gastric neuroendocrine carcinoma with non-islet cell tumor hypoglycemia associated with enhanced production of insulin-like growth factor II. Intern Med (2013) 0.85
A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis. World J Surg (2012) 0.85
Twenty-two metachronous multiple signet-ring cell carcinomas treated with repeated gastrectomies and repeated endoscopic mucosal resections: report of a case. Surg Today (2009) 0.85
Management of low-risk papillary thyroid carcinoma: unique conventional policy in Japan and our efforts to improve the level of evidence. Surg Today (2010) 0.83
Laminin-5 gamma2 chain expression as a possible determinant of tumor aggressiveness in T1 colorectal carcinomas. Dig Dis Sci (2003) 0.83
Sonographic findings in three cases of carcinoma showing thymus-like differentiation. J Clin Ultrasound (2012) 0.83
Daily low-dose cisplatin-based concurrent chemoradiotherapy in patients with uterine cervical cancer with emphasis on elderly patients: a phase 2 trial. Int J Gynecol Cancer (2013) 0.82
Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Anticancer Res (2007) 0.82
Tumor budding and evidence-based treatment of T2 rectal carcinomas. J Surg Oncol (2005) 0.82
Mechanism of edge restenosis after sirolimus-eluting stent implantation. J Invasive Cardiol (2012) 0.82
Expansion of indications for endoscopic treatment of undifferentiated mucosal gastric cancer: analysis of intramucosal spread in resected specimens. Dig Dis Sci (2009) 0.82
Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results. Int J Urol (2004) 0.82
Intracoronary Acetylcholine Provocation Testing - Omission of the 20-µg Dose Is Feasible in Patients Without Coronary Artery Spasm in the Other Coronary Artery. Circ J (2016) 0.82
Incidence and prognostic value of lymph node metastasis on c-Kit-positive gastrointestinal stromal tumors of the stomach. Hepatogastroenterology (2011) 0.81
Can narrow-band imaging be used to determine the surgical margin of superficial hypopharyngeal cancer? Acta Med Okayama (2008) 0.81
Decreased expression of the thyroid-stimulating hormone receptor in poorly-differentiated carcinoma of the thyroid. Oncol Rep (2008) 0.81
Morphological characteristics of lateral pelvic lymph nodes in rectal carcinoma. Langenbecks Arch Surg (2007) 0.81
Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases. Surg Today (2015) 0.81
Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: retrospective analysis of 4 Japanese hospitals. Circ J (2009) 0.80
Mechanism of the tissue-specific action of the selective androgen receptor modulator S-101479. Biol Pharm Bull (2013) 0.80
Colonic Marking With Near-Infrared, Light-Emitting, Diode-Activated Indocyanine Green for Laparoscopic Colorectal Surgery. Dis Colon Rectum (2016) 0.80
Expression of Ca²⁺-dependent activator protein for secretion 2 is increased in the brains of schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.80
Support for association between the Ser205Leu polymorphism of p75(NTR) and major depressive disorder. J Hum Genet (2011) 0.80
Purification, characterization, and overexpression of psychrophilic and thermolabile malate dehydrogenase of a novel antarctic psychrotolerant, Flavobacterium frigidimaris KUC-1. Biosci Biotechnol Biochem (2005) 0.80
Divergent expression of L-type amino acid transporter 1 during uterine cervical carcinogenesis. Hum Pathol (2011) 0.80
Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J Gastroenterol Hepatol (2006) 0.80
Anti-androgenic effects of S-40542, a novel non-steroidal selective androgen receptor modulator (SARM) for the treatment of benign prostatic hyperplasia. Prostate (2012) 0.80
Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg (2014) 0.79
Metastatic thyroid tumors: ultrasonographic features, prognostic factors and outcomes in 29 cases. Surg Today (2013) 0.79
Mycobacterial infection of the musculoskeletal tissues: the use of pathological specimens for identification of causative species by PCR-direct sequencing of 16S rDNA. Jpn J Infect Dis (2010) 0.79
Novel mouse model for Gardner syndrome generated by a large-scale N-ethyl-N-nitrosourea mutagenesis program. Cancer Sci (2013) 0.79
Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon. Int J Gynecol Pathol (2011) 0.79
Sudden unexpected death in patients with malignancy: a clinicopathologic study of 28 autopsy cases. Pathol Res Pract (2006) 0.79
Leiomyosarcoma with dedifferentiation in a premenopausal patient discovered after uterine artery embolization. Pathol Int (2007) 0.79
Complete resection after imatinib treatment of a gastrointestinal stromal tumor of the ileum with peritoneal metastases: report of a case. Surg Today (2010) 0.79
Surgery did not improve the subjective neuropsychological symptoms of patients with incidentally detected mild primary hyperparathyroidism. Eur Arch Otorhinolaryngol (2007) 0.79
Efficacy and safety of low-dose clopidogrel in Japanese patients after drug-eluting stent implantation: a randomized pilot trial. Heart Vessels (2012) 0.78
Magnifying endoscopy with narrow-band imaging findings in the diagnosis of Barrett's esophageal adenocarcinoma spreading below squamous epithelium. Dig Endosc (2013) 0.78
The novel non-steroidal selective androgen receptor modulator S-101479 has additive effects with bisphosphonate, selective estrogen receptor modulator, and parathyroid hormone on the bones of osteoporotic female rats. Biol Pharm Bull (2012) 0.78
Endocrine therapy with or without radical prostatectomy for T1b-T3N0M0 prostate cancer. Int J Urol (2004) 0.78
The Efficacy of Palonosetron Plus Dexamethasone in Preventing Chemoradiotherapy-induced Nausea and Emesis in Patients Receiving Daily Low-dose Cisplatin-based Concurrent Chemoradiotherapy for Uterine Cervical Cancer: A Phase II Study. Am J Clin Oncol (2017) 0.77